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Abstract
Successful quantitative mass spectrometry (MS) requires strategies to link the mass spectrometer
response to the analyte abundance, with the response being dependent on more factors than just
analyte abundance. Label-dependent strategies rely on the incorporation of an isotopically labeled
internal standard into the sample. Current label-free strategies (performed without internal
standards) are useful for analyzing samples that are unsuitable for isotopic labeling but are less
accurate. Here we describe a label-free technique applicable to analysis of products from related
genes (isotypes). This approach enables the invariant tryptic peptide sequences within the family
to serve as “built-in” internal standards and the isotype-specific peptide sequences to report the
amount of the various isotypes. A process of elimination segregates reliably trypsin-released
standard and reporter peptides from unreliably released peptides. The specific MS response factors
for these reporter and standard peptides can be determined using synthetic peptides. Analysis of
HeLa tubulin digests revealed peptides from βI-, βII-, βIII-, βIVb-, and βV-tubulin, eight of which
were suitable; along with five standard peptides for quantification of the β-tubulin isotypes. To
show the utility of this method, we determined that βI-tubulin represented 77% and βIIItubulin
represented 3.2% of the total HeLa β-tubulin.
Keywords
Label-free quantification; Mass spectrometry; Targeted proteomic analysis; Tubulin isotype
quantification; Tubulin
During recent years, mass spectrometry (MS)1 has become the preferred technique to
resolve and quantify gene products in crude cellular extracts—an endeavor more commonly
referred to as proteomics. The reason is that the modern liquid chromatography (LC)–MS
device delivers unparalleled sensitivity, specificity, and resolving power in addition to being
easily adapted for high-throughput analysis [1]. Although LC–MS excels at detecting and
identifying an analyte, a task it is capable of performing in a single experiment using tandem
mass spectrometry (MS/MS), quantification is more challenging. This is reflected by the
profusion of quantitative mass spectrometry (QMS) techniques currently in use (reviewed in
Refs. [1–3]). Most protein QMS techniques share a common work flow in which the intact
purified protein or extract is digested proteolytically or chemically and the resulting peptide
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mixture is resolved by LC. Then it is analyzed by an electrospray ionizing mass
spectrometer coupled directly to the LC device [1]. The difference in the techniques lies in
the unique way in which they overcome the intrinsic limitations of quantification by MS.
These limitations stem from the fact that the response of the MS detector is dependent on
more factors than just analyte abundance. The additional factors include the nature of the
sample, the matrix, and both the chromatographic and ionization conditions [1]. Because
proteolytic peptides display a wide range of physicochemical properties, peptide ion LC–MS
molar response factors can vary over two orders of magnitude. This necessitates that a
calibration or comparison strategy be implemented to link the LC–MS response to the
abundance of each peptide. The various QMS techniques can be categorized based on
whether the method of comparison or calibration is dependent on the addition of isotopic
labels (label dependent) or not (label free).
Label-dependent QMS techniques employ differential labeling to add inert (stable isotopic)
mass tags to every protein in the sample. The peptides derived from these proteins then
function as a “built-in” internal standard. The labeled and unlabeled samples are combined
prior to digestion and MS analysis, ensuring that the digestion, chromatographic, and
ionization conditions are identical for both the internal standard and the analyte. For this
reason, label-dependent QMS techniques are considered to be the most precise and accurate
of the QMS techniques [4–11].
Label-free techniques compare the quantitative data from multiple LC–MS analyses
performed without incorporating an isotopic label into the samples [1,3]. Robust
quantification by label-free techniques requires more MS injections per sample to build a
dataset large enough to permit valid statistical analysis. The additional statistical analysis is
required to correct for systematic error in each experiment [1,12,13]. Label-free QMS is
preferred in situations where incorporating isotopic labels prior to proteolytic digestion is
made impractical or even impossible by difficulties in obtaining enough material from
which to extract sufficient protein for analysis. Although post-digest labeling techniques
exist, using them introduces additional sources of random sample variation and any
incremental increase in accuracy over label-free QMS might not justify the extra effort,
expense, and complication of reliably incorporating isotopic labels into the sample.
In the context of a targeted analysis of a proteome, there is a niche where a label-free QMS
technique is the most sensible approach, namely quantifying the products from related genes
(isotypes). Protein families applicable to such examination include cytochrome P450
isozymes, kinesins, dyneins, chaperones (e.g., the Hsp70 family), and tubulin. A feature of
these gene product families is the opportunity to use the invariant amino acid sequences
within the families as built-in internal standards and to use the isotype-specific portions of
the sequence to report the amount of the various isotypes. We present tubulin as an
archetype of this approach.
Humans express seven β-tubulin protein isotypes (βI, βII, βIII, βIVa, βIVb, βV, and βVI)
with very similar protein sequences, with the principal source of sequence divergence
residing in the final 20 C-terminal residues [14–16]. Tubulin is the subject of intensive
investigation because changes in the expression pattern of β-tubulin isotypes have been
implicated in drug-resistant malignancies. For this reason, attempts have been made to
determine the expression patterns of β-tubulin isotypes in a number of cell lines and tissues.
A sensitive generalized approach to isotype quantification of tubulin would significantly
improve the ability to determine the role of tubulin in cell biology and possibly human
disease intervention.
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Quantification of isotypes within a single family of proteins relies on the fact that the
abundance of unique tryptic peptides will reflect the abundance of the parent protein [17,18].
This statement is predicated on the observation that every member of the protein family is
essentially an identical substrate of trypsin. For example, it has long been established that
members of both the human αand β-tubulin families are highly homologous, overall, in
terms of both sequence and tertiary structure [19]. Thus, the abundance of those reliably
released tryptic peptides that are ubiquitous to every member of either the α- or β-tubulin
family (standard peptides) should reflect the total concentration of α- and β-tubulin in the
sample. Furthermore, because α- and β-tubulin are present in a 1:1 molar ratio within
microtubules [19], the abundance of standard peptides from either α- or β-tubulin will
reflect the concentration of both α- and β-tubulin within the sample.
Our label-free method for quantifying tubulin isotypes encompassed three phases. First, we
identified potential standard and reporter peptides present in tryptic digests of purified HeLa
tubulin. Second, we identified the reliably released peptides within this subset to ensure that
the abundance of reporter and standard peptides always reflects the abundance of the parent
protein(s). We define standard peptides as reliably released tryptic peptides common to all
protein isotypes found in the sample. Reporter peptides are reliably released tryptic peptides
that are unique to a particular isotype. Finally, we determined the peptide-specific LC–MS
response factors for a selection of these reporter and standard peptides. In so doing, we were
able to derive an absolute estimate of the abundance of βI- and βIII-tubulin in HeLa cells.
Materials and methods
General materials and protocols
HeLa tubulin was a kind gift from Mary Ann Jordan (University of California, Santa
Barbara). Saccharomyces cerevisiae strain AD1–8 [20] tubulin was purified as described
previously [21,22]. Protein concentration was determined using the Bradford assay [23].
Tubulin digests
Sequencing-grade trypsin (Promega, Madison, WI, USA) was used for all digestions. All
tryptic digestions were carried out at 37 °C for 16–20 h. BioSpin 6 columns (Bio-Rad,
Hercules, CA, USA) were used to exchange the buffers in the protein solutions to 50
mMNH4HCO3 (pH 7.8) prior to proteolysis. HeLa tubulin was digested in a 50-µl solution
consisting of 0.25 µg/µl tubulin and 12.5 ng/µl trypsin in 50 mM NH4HCO3 (pH 7.8). S.
cerevisiae tubulin was digested in a 25-µl solution consisting of 1.0 µg/µl tubulin and 62.5
ng/µl trypsin in 50 mM NH4HCO3, into which was added 2–8 µl of the synthetic peptide
solution (see below). The S. cerevisiae tubulin was digested to produce a matrix, into which
the synthetic peptides could be placed, that would approximate that found in HeLa tubulin
digests without interfering with the quantification of the synthetic peptides.
Peptide nomenclature
In this study, reporter peptides are assigned an alphanumeric code that reflects their parent
isotype. BI-n denotes a reporter peptide for βI-tubulin (the numerals are assigned randomly),
BII-n denotes the nth reporter peptide for βII-tubulin, and so on. Standard peptides are
defined as tryptic peptides that are present in, and reliably released from, every protein
isotype within a family, a property that enables them to be used as an internal standard for
quantification. In this context, the standard peptides originate from either α-tubulin or β-
tubulin. Standard peptides from α-tubulin were designated as AA-n to denote their presence
in all α-tubulin isotypes (i.e., “all alpha”). Likewise standard peptides from β-tubulin were
designated AB-n.
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Two of the standard peptides (AA-3, EDMAALEK, 906.02 Da, and AB-1, FPGQLNADLR,
1130.27 Da) and two of the reporter peptides (BI-1, ALTVPELTQQVFDAK, 1659.90 Da,
and BIII-3, LATPTYGDLNH LVSATMSGVTTSLR, 2605.95 Da) were selected for
synthesis for the purpose of determining the unique LC–MS response factor for each.
Synthesis was performed by GeneScript (Scotch Plains, NJ, USA). An aqueous mixture of
these synthetic peptides (100 µMAA-3, 100 µM AB-1, 80 µM BI-1, and 13 µM BIII-3 in
deionized water) was prepared prior to use. The molar ratio of peptides reflects the relative
concentration of the βI isotype as determined by Newton and coworkers, with sufficient
BIII-3 being added to ensure a suitable signal [24].
Capillary HPLC mass spectroscopic analysis of tryptic digests
The presence of the reporter peptides in each digest was confirmed by MS/MS experiments
performed contemporaneously with quantitative LC–MS injections. Following tryptic
digestion, samples were diluted either 5- or 20-fold in 50 mM NH4HCO3 (pH 7.8), and 5 µl
was injected into a Zorbax C18 column (300 µM × 5 cm, 5 µMparticle size, 300 Å pore size,
MicroTech Scientific, Vista, CA, USA). The peptides were eluted with a linear gradient
from 1% to 94% CH3CN, 0.08% formic acid, over 70 min. Total column effluent (6 µl/min)
was connected to an LTQ-FT hybrid mass spectrometer (Thermo Scientific, Bremen,
Germany) operated in one of two modes. For MS/MS experiments, the data were obtained
from a full-scan MS survey in FT mode (25,000 resolution and fill target of 1 × 105). The
three most abundant ions in the survey were fragmented in the linear ion trap for a fill to 5 ×
103 or 200 ms, and the ions were excluded from reanalysis for 30 s. Spectra used for
quantification were acquired in FT full-scan mode at 50,000 resolution, 3 micro scans, and a
fill target of 1 × 105 or 1000 ms maximum fill time.
Spectrum processing and collection of XIC data
The LC–MS spectra were processed by hand. The identity of all peptides investigated was
confirmed by MS/MS performed on one of the 18 digests that comprised this study, and
thereafter the identity was established based on the observed m/z ratio. Extracted ion
chromatograms (XICs) specific to the monoisotopic peptide ion were obtained using
Xcalibur software (Thermo Scientific, Waltham, MA, USA). For all ions, the XIC
parameters were the m/z ratio of the monoisotopic ion plus/minus the full-width half-
maximum (FWHM) of the m/z signal. The area of this XIC peak (hereafter referred to as the
LC–MS signal) was determined by integration using Xcalibur software. For peaks with poor
peak shape, the integration parameters were restricted to maintain a constant peak width at
half height on the LC peaks. Limits of detection and quantitation were calculated (in
accordance with International Union of Pure and Applied Chemistry (IUPAC) guidelines
[25]) using intensity of the strongest m/z signal in the XIC that was unassociated with an ion
cluster. It was necessary to calculate the limits for each peptide individually due to
background signal variation across the chromatographic spectrum.
Protein quantification
Peptide signal response factors (signal/mole peptide injected) in LC–MS can vary by
sequence and daily instrument conditions. To compare signals across samples, multiple
injections, and different days requires normalization of signals to some in-sample internal
standard. Depending on the experiment, one of three normalization strategies was applied in
this work. When assessing the experimental error intrinsic to the LC–MS system, raw LC–
MS data were used to construct a pairwise comparison table composed of ratios of the LC–
MS signal for every pair of identifiable peptides detected in a single injection. “Identifiable”
was taken to mean an exact mass corresponding to a tubulin tryptic fragment. For each
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digest, the mean and standard deviation (SD) of the ratios for each peptide pair were
calculated using the ratios collected from triplicateLC–MS injections of each digest. The
coefficient of variation (CV) of the ratios for all ratio data obtained from the digest were
averaged to establish the baseline level of signal variance (the mean CV for all peptide pairs
in that injection) for the LC–MS system independent of trypsin activity.
This procedure was modified to judge the reliability of the peptide’s release. The SD and
mean CV of ratios (across all digests) for each peptide pair were calculated. By trial and
error, data derived from a single peptide were omitted from the calculated ratios and the CV
statistics across all digests were recalculated. Peptides that trypsin releases unreliably skew
the mean CV and inflate the SD. Recalculating the CV statistics without unreliable ratio data
derived from them will systematically reduce the SD while simultaneously lowering the
mean CV. When the subset of peptides has been reduced to the point where the recalculated
mean CV is less than or equal to the recalculated baseline value, the analysis is complete.
Peptides deemed to be unreliable by this method were excluded from further analysis.
Results
Selecting reporter ions
Alignment and virtual digest analysis, conducted on the known sequences of every isotype
in the tubulin family, is an essential first step in the task of identifying standard and reporter
peptides because these will form a limited subset of the tryptic peptides present in the digest.
Three criteria were applied to the selection of appropriate standard and reporter peptides.
Any peptides that did not meet all three criteria were discarded. First, the peptide ions had a
distinct and easily identifiable LC–MS signal (e.g., an uninterrupted ion cluster with a mass
spectrum signal at least 10 times higher than the limit of quantitation) so as to facilitate
accurate quantification across multiple digests. Second, the identity of these peptide ions
was confirmed first by MS/MS and thereafter by inspection of the peptide’s m/z ratio. The
resolution and mass accuracy of the LTQ-FT hybrid mass spectrometer (<5 ppm) enabled us
to identify our standard and reporter peptides in this manner based solely on their m/z ratio
without further MS/MS experiments. Third, the precision and accuracy of measurement by
this method are limited not just by precision and accuracy of the LC–MS device but also by
the reliability of tryptic release. We define reliably released peptides as those whose
observed abundance, relative to other peptides, does not vary between identical tryptic
digests. In essence, this means selecting peptides with the least dispersion in LC–MS signals
between digests.
Logically, the ratio of the respective abundances for two reliably released peptides will
remain unchanged between independent but equivalent digests. This entails examining the
magnitude of data dispersion observed across many injections or digests. Note that the CV, a
normalized measure of dispersion, is used in lieu of the SD to permit the analysis of ratios
from any combination of peptides, enabling the averaging of all ratios (all peptide
combinations) observed in a single LC–MS injection. The mean CV of peptide ratios
(independent of trypsin activity) in three LC–MS injections from a single digest was 26%.
Unreliable peptides can then be identified by trial and error if the CV statistics from multiple
independent digests for ratios comprising a common peptide are compiled and then
recalculated after excluding ratios of a particular peptide pairing. If the second peptide in
that pair was unreliably released, the mean CV of the remaining ratios should decrease in
every instance where the abundance of the unreliable peptide is compared with another. The
process is complete when the adjusted mean CV for the remaining peptides is less than or
equal to 26%, the variance observed independent of trypsin activity. The effects of these
analyses are illustrated with box and whisker plots that display range, mean, and
interquartile statistics (Fig. 1). When the modified data are plotted, it is apparent that the
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excluded peptides have contributed to the exaggerated dispersion and elevated mean CV
seen in the plots of unmodified data.
MS/MS experiments had identified 9 tryptic peptides with the potential to be used as
standards in this analysis and an additional 15 peptides unique to particular isotypes of β-
tubulin. Tryptic peptides from six β-tubulin isotypes (βI, βII, βIII, βIVa, βIvb, and βV) were
detected (Table 1). This is the first time that βIVa and βV have been detected in HeLa
tubulin. Applying the strategy described above to data from three independent digests, 5 of
the 9 potential standard peptides and 8 of the 15 potential reporter peptides were shown to
be reliably released (Table 1).
Peptide-specific LC–MS response factors
We determined the LC–MS response factors for two standard peptides (AA-3 and AB-1)
and two reporter peptides (BI-1 and BIII-3) that could be used to quantify the β1 and βIII
isotypes. The peptides were synthesized and a mixture of all four synthetic peptides was
added, in increasing concentration, to samples of purified S. cerevisiae tubulin prior to
digestion with trypsin. The yeast tubulin digest provides a sample matrix that mimics the
matrix found in digests of HeLa tubulin without interfering with the quantification of the
synthetic peptides; the synthetic peptides being measured are absent from the two α-tubulin
proteins and one β-tubulin protein produced by S. cerevisiae. The peptides were quantified,
in quintuplicate, at four concentrations for a total of 20 independent digests and LC–MS
injections. Reliably released tryptic peptides from S. cerevisiae tubulin were used as internal
standards to normalize the data from each experiment prior to determining the response
factors (Table 2) for each synthetic peptide using linear regression analysis (Fig 2).
Quantitative analysis
A total of 15 replicate tryptic digests of HeLa tubulin were prepared and injected over a 96-h
period. A typical ion chromatogram for these LC–MS injections is shown in Fig. 3.
Quantitative data were obtained from XICs from each digest and analyzed manually.
Reporter peptide data were normalized to help mitigate error; the correction factor for each
digest was derived by considering the relative LC–MS response of all six standard peptides.
The mean LC–MS signals for the four peptides for which response factors were determined
after normalization are presented in Table 3. The concentration of each of these peptides was
calculated by dividing the mean LC–MS signal for a peptide (and obtained from a known
volume of sample) by the appropriate response factor (Table 2). Using the mean absolute
abundance of AA-3 and AB-1 standards, a figure of 2.54 pmol/µl for total tubulin was
computed. The Bradford protein assay obtained independently of the LC–MS results showed
that the total concentration of β-tubulin in the digests was 2.5 pmol/µl (data not shown).
Discussion
We have described a method by which the sensitivity and selectivity of modernLC–MS
techniques may be applied to the quantification of closely related proteins or the comparison
of separate samples without the need for isotopic labeling or the addition of internal
standards to samples. The method is simple, specific, and sensitive. The QMS method
described here has the advantage of not requiring the manipulations required to introduce
isotopically labeled peptides. As with label-dependent QMS methods, this method permits
the accurate comparison of dissimilar samples because a built-in peptide-based internal
standard is available to calibrate the LC–MS signals from each sample. We envision this
technique being useful to laboratories seeking a simple, accurate, and sensitive technique to
determine the abundance of proteins with homologous sequences such as isotypes or
mutated forms of a particular protein and proteins that are closely related. The fundamental
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perquisite, or possible limitation, of this strategy is implied in this work and in a related
quantification of cytochrome p450 isozymes by matrix-assisted laser desorption/ionization
(MALDI) [26]. A protein family must be enriched to the point were the isotype reporter
peptide of least abundance is detectable. The standard and reporter peptides for tubulin in
the current work and the reporter peptides in the P450 work [26] will be reliable for all MS
methods, but the specific sensitivity and application to a given sample is driven by the
sample preparation and available instrumentation.
We applied this technique to HeLa tubulin and were able to detect βII, βIVa, and βV-tubulin
in HeLa tubulin for the first time. Moreover, we easily detected the βIII isotype and were
able to quantify its concentration. Previous studies, using immunostaining, failed to detect
βIII-tubulin in purified HeLa tubulin [24] or HeLa cell extracts [27] except by overloading
the gels [24]. Accurate measurements of analyte abundance using antibodies are
complicated by significant variations in the reactivity shown by individual antibodies for
their targets [28,29]. Verdier-Pinard and coworkers did detect βIII-tubulin in HeLa tubulin
when they examined undigested HeLa tubulin samples by LC–MS [30] but were unable to
detect the C-terminal peptide of the βIII isotype when they examined CNBr digests of HeLa
tubulin using MALDI–time-of-flight (TOF). In addition, they were unable to detect βII-,
βIVa, or βV-tubulin. There is much interest in determining the levels of βIII-tubulin in
mammalian cells as mounting clinical evidence demonstrates a correlation between
increased expression of this normally neuronal specific isotype and resistance to
chemotherapeutic agents [31–39]. Investigations in this field require quantitative techniques
that are able to detect perturbations in the natural abundance of all isotypes, and we believe
that the technique described here is ideally suited for this.
Acknowledgments
We thank Mary Ann Jordan for her kind gift of purified HeLa tubulin and Melinda L. Toumi for her helpful
suggestions during the preparation of this manuscript. This work was supported by National Institutes of Health
(NIH) Grant CA 105305.
References
1. Bantscheff M, Schirle M, Sweetman G, Rick J, Kuster B. Quantitative mass spectrometry in
proteomics: a critical review. Anal. Bioanal. Chem. 2007; 389:1017–1031. [PubMed: 17668192]
2. Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature. 2003; 422:198–207.
[PubMed: 12634793]
3. Thelen JJ, Peck SC. Quantitative proteomics in plants: choices in abundance. Plant Cell. 2007;
19:3339–3346. [PubMed: 18055608]
4. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R. Quantitative analysis of complex
protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 1999; 17:994–999. [PubMed:
10504701]
5. Oda Y, Huang K, Cross FR, Cowburn D, Chait BT. Accurate quantitation of protein expression and
site-specific phosphorylation. Proc. Natl. Acad. Sci. USA. 1999; 96:6591–6596. [PubMed:
10359756]
6. Paša-Tolić L, Jensen PK, Anderson GA, Lipton MS, Peden KK, Martinovic S, Tolic N, Bruce JE,
Smith RD. High-throughput proteome-wide precision measurements of protein expression using
mass spectrometry. J. Am. Chem. Soc. 1999; 121:7949–7950.
7. Ong SE, Mann M. Mass spectrometry-based proteomics turns quantitative. Nat. Chem. Biol. 2005;
1:252–262. [PubMed: 16408053]
8. Yao X, Freas A, Ramirez J, Demirev PA, Fenselau C. Proteolytic 18O labeling for comparative
proteomics: model studies with two serotypes of adenovirus. Anal. Chem. 2001; 73:2836–2842.
[PubMed: 11467524]
Winefield et al. Page 7













9. Ross PL, Huang YN, Marchese JN, Williamson B, Parker K, Hattan S, Khainovski N, Pillai S, Dey
S, Daniels S, Purkayastha S, Juhasz P, Martin S, Bartlet-Jones M, He F, Jacobson A, Pappin DJ.
Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging
reagents. Mol. Cell. Proteomics. 2004; 3:1154–1169. [PubMed: 15385600]
10. Schmidt MW, Houseman A, Ivanov AR, Wolf DA. Comparative proteomic and transcriptomic
profiling of the fission yeast Schizosaccharomyces pombe. Mol. Syst. Biol. 2007; 3:79. [PubMed:
17299416]
11. Gerber SA, Rush J, Stemman O, Kirschner MW, Gygi SP. Absolute quantification of proteins and
phosphoproteins from cell lysates by tandem MS. Proc. Natl. Acad. Sci. USA. 2003; 100:6940–
6945. [PubMed: 12771378]
12. Old WM, Meyer-Arendt K, Aveline-Wolf L, Pierce KG, Mendoza A, Sevinsky JR, Resing KA,
Ahn NG. Comparison of label-free methods for quantifying human proteins by shotgun
proteomics. Mol. Cell. Proteomics. 2005; 4:1487–1502. [PubMed: 15979981]
13. America AH, Cordewener JH. Comparative LC–MS: a landscape of peaks and valleys. Proteomics.
2008; 8:731–749. [PubMed: 18297651]
14. Luduena RF. Multiple forms of tubulin: different gene products and covalent modifications. Intl.
Rev. Cytol. 1998; 178:207–275.
15. Khodiyar VK, Maltais LJ, Sneddon KM, Smith JR, Shimoyama M, Cabral F, Dumontet C, Dutcher
SK, Harvey RJ, Lafanechere L, Murray JM, Nogales E, Piquemal D, Stanchi F, Povey S, Lovering
RC. A revised nomenclature for the human and rodent α-tubulin gene family. Genomics. 2007;
90:285–289. [PubMed: 17543498]
16. Verdier-Pinard P, Pasquier E, Xiao H, Burd B, Villard C, Lafitte D, Miller LM, Angeletti RH,
Horwitz SB, Braguer D. Tubulin proteomics: towards breaking the code. Anal. Biochem. 2009;
384:197–206. [PubMed: 18840397]
17. Chelius D, Bondarenko PV. Quantitative profiling of proteins in complex mixtures using liquid
chromatography and mass spectrometry. J. Proteome Res. 2002; 1:317–323. [PubMed: 12645887]
18. Bondarenko PV, Chelius D, Shaler TA. Identification and relative quantitation of protein mixtures
by enzymatic digestion followed by capillary reversed-phase liquid chromatography–tandem mass
spectrometry. Anal. Chem. 2002; 74:4741–4749. [PubMed: 12349978]
19. Nogales E, Wolf SG, Downing KH. Structure of the αβ-tubulin dimer by electron crystallography.
Nature. 1998; 391:199–203. [PubMed: 9428769]
20. Decottignies A, Grant AM, Nichols JW, de Wet H, McIntosh DB, Goffeau A. ATPase and
multidrug transport activities of the overexpressed yeast ABC protein Yor1p. J. Biol. Chem. 1998;
273:12612–12622. [PubMed: 9575223]
21. Gupta ML Jr, Bode CJ, Georg GI, Himes RH. Understanding tubulin–Taxol interactions: mutations
that impart Taxol binding to yeast tubulin. Proc. Natl. Acad. Sci. USA. 2003; 100:6394–6397.
[PubMed: 12740436]
22. Foland TB, Dentler WL, Suprenant KA, Gupta ML Jr, Himes RH. Paclitaxel-induced microtubule
stabilization causes mitotic block and apoptotic-like cell death in a paclitaxel-sensitive strain of
Saccharomyces cerevisiae. Yeast. 2005; 22:971–978. [PubMed: 16134117]
23. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein
utilizing the principle of protein–dye binding. Anal. Biochem. 1976; 72:248–254. [PubMed:
942051]
24. Newton CN, DeLuca JG, Himes RH, Miller HP, Jordan MA, Wilson L. Intrinsically slow dynamic
instability of HeLa cell microtubules in vitro. J. Biol. Chem. 2002; 277:42456–42462. [PubMed:
12207023]
25. Long GL, Winefordner JD. Limits of detection: a closer look at the IUPAC definition. Anal. Chem.
1983; 55:712A–724A.
26. Alterman MA, Kornilayev B, Duzhak T, Yakovlev D. Quantitative analysis of cytochrome p450
isozymes by means of unique isozyme-specific tryptic peptides: a proteomic approach. Drug
Metab. Dispos. 2005; 33:1399–1407. [PubMed: 15951447]
27. Risinger AL, Jackson EM, Polin LA, Helms GL, LeBoeuf DA, Joe PA, Hopper-Borge E, Luduena
RF, Kruh GD, Mooberry SL. The taccalonolides: microtubule stabilizers that circumvent clinically
relevant taxane resistance mechanisms. Cancer Res. 2008; 68:8881–8888. [PubMed: 18974132]
Winefield et al. Page 8













28. Hagman C, Ricke D, Ewert S, Bek S, Falchetto R, Bitsch F. Absolute quantification of monoclonal
antibodies in biofluids by liquid chromatography–tandem mass spectrometry. Anal. Chem. 2008;
80:1290–1296. [PubMed: 18217771]
29. Lehmann U, Wienkoop S, Tschoep H, Weckwerth W. If the antibody fails: a mass Western
approach. Plant J. 2008; 55:1039–1046. [PubMed: 18485062]
30. Verdier-Pinard P, Wang F, Burd B, Angeletti RH, Horwitz SB, Orr GA. Direct analysis of tubulin
expression in cancer cell lines by electrospray ionization mass spectrometry. Biochemistry. 2003;
42:12019–12027. [PubMed: 14556633]
31. Kamath K, Wilson L, Cabral F, Jordan MA. βIII-Tubulin induces paclitaxel resistance in
association with reduced effects on microtubule dynamic instability. J. Biol. Chem. 2005;
280:12902–12907. [PubMed: 15695826]
32. Katsetos CD, Herman MM, Mork SJ. Class III β-tubulin in human development and cancer. Cell
Motil. Cytoskel. 2003; 55:77–96.
33. Pasquier E, Kavallaris M. Microtubules: a dynamic target in cancer therapy. IUBMB Life. 2008;
60:165–170. [PubMed: 18380008]
34. Gan PP, Pasquier E, Kavallaris M. Class III β-tubulin mediates sensitivity to chemotherapeutic
drugs in non-small cell lung cancer. Cancer Res. 2007; 67:9356–9363. [PubMed: 17909044]
35. Seve P, Lai R, Ding K, Winton T, Butts C, Mackey J, Dumontet C, Dabbagh L, Aviel-Ronen S,
Seymour L, Whitehead M, Tsao MS, Shepherd FA, Reiman T. Class III β-tubulin expression and
benefit from adjuvant cisplatin/vinorelbine chemotherapy in operable non-small cell lung cancer:
analysis of NCIC JBR.10. Clin. Cancer Res. 2007; 13:994–999. [PubMed: 17289895]
36. Hayashi Y, Kuriyama H, Umezu H, Tanaka J, Yoshimasu T, Furukawa T, Tanaka H, Kagamu H,
Gejyo F, Yoshizawa H. Class III β-tubulin expression in tumor cells is correlated with resistance
to docetaxel in patients with completely resected non-small-cell lung cancer. Intern. Med. 2009;
48:203–208. [PubMed: 19218769]
37. Seve P, Mackey J, Isaac S, Tredan O, Souquet PJ, Perol M, Lai R, Voloch A, Dumontet C. Class
III β-tubulin expression in tumor cells predicts response and outcome in patients with non-small
cell lung cancer receiving paclitaxel. Mol. Cancer Ther. 2005; 4:2001–2007. [PubMed: 16373715]
38. Burkhart CA, Kavallaris M, Band Horwitz s. The role of β-tubulin isotypes in resistance to
antimitotic drugs. Biochim. Biophys. Acta. 2001; 1471:O1–O9. [PubMed: 11342188]
39. Dumontet C, Jordan MA, Lee FF. Ixabepilone: targeting βIII-tubulin expression in taxane-resistant
malignancies. Mol. Cancer Ther. 2009; 8:17–25. [PubMed: 19139109]
Winefield et al. Page 9














(A) Box and whisker plots displaying the distribution of observed abundance ratios of
standard peptides from multiple tryptic digests of HeLa tubulin. Unshaded box and whisker
plots show the dispersion of the CVs of abundance ratios for every nonredundant
combination of potential standard peptides. Shaded box and whisker plots were replotted
after omitting data obtained from peptides AA-1, AA-2, and AA-4. The omission reduces
both the range (represented by the length of the plot whiskers) and interquartile range
(represented by the length of the box). This indicates that the total variance has decreased.
Max., maximum; Min., minimum. (B) Box and whisker plots of the CVs of abundance ratios
for potential reporter peptides paired with the reliable standard peptides identified in (A).
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Peptides with a median score above the established baseline median CV (26%) are deemed
to be unreliably released by trypsin and not used for analysis.
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Linear regression analysis to determine the LC–MS response factors for select standard and
reporter peptides (data given in Table 2). Mean LC–MS signal is defined as the integrated
area under the XIC chromatographic peak determined to belong to the peptide. Error bars
depict the SD. MC, machine counts. The response factor and R2 data were calculated by
linear regression analysis using Prism 4.03 software (GraphPad Software, San Diego, CA,
USA).
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Typical chromatographic elution profiles for a tryptic digest of HeLa tubulin. (A) Peaks
containing peptides AA-3, AB-1, BI-1, and BIII-3. (B–E) Mass spectra for peptides AA-3
(B), AB-1 (C), BI-1 (D), and BIII-3 (E).
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Table 1
Sequences, origins, charges, and masses of standard and reporter peptide ions detected in this study
Code Sequence Charge Mass (Da)
Standard peptides
All α-tubulin
  AA-1 403AFVHWYVGEGMEEGEFSEAR422 3 777.3555
  AA-2 97EDAANNYAR105 2 512.2284
  AA-3 423EDMAALEK430 2 453.7163
  AA-4 244FDGALNVDLTEFQTNLVPYPR264 3 803.7487
  AA-5 216NLDIERPTYTNLNR229 2 859.9463
  AA-6 353VGINYQPPTVVPGGDLAK370 2 912.9999
  AA-7 85QLFHPEQLITGK105 2 705.9012
All β-tubulin
  AB-1 242FPGQLNADLR251 2 565.8030
  AB-2 253LAVNMVPFPR262 2 572.3210
Reporter peptides
βI (P07437)
  BI-1 283ALTVPELTQQVFDAK297 2 830.4569
  BI-2 20FWEVISDEHGIDPTGTYHGDSDLQLDR46 3 1034.8159
  BI-3 363MAVTFIGNSTAIQELFK379 2 935.4968
βII (Q9BVA1)
  BII-1 47INVYYNEAAGNK58 2 678.3334
βIII (Q13509)
  BIII-1 20FWEVISDEHGIDPSGNYVGDSDLQLER46 3 1026.4879
  BIII-3 217LATPTYGDLNHLVSATMSGVTTSLR241 3 869.1196
  BIII-4 363MSSTFIGNSTAIQELFK379 2 937.4802
βIVa and βIVb (P68371 and P04350)
  BIVa-1 363MAATFIGNSTAIQELFK379 2 929.4765
  BIVb-1 47INVYYNEATGGK58 2 664.8292
βV (Q9BUF5)
  BV-1 63AALVDLEPGTMDSVR77 2 787.4001
  BV-2 283ALTVPELTQQMFDAR297 2 860.4439
  BV-3 217LTTPTYGDLNHLVSATMSGVTTSLR241 3 879.1298
  BV-4 363MASTFIGNSTAIQELFK379 2 929.4793
  BV-5 78SGPFGQLFRPDNFIFGQTGAGNNWAK103 3 942.8004
  BV-6 20FWEVISDEHGIDPAGGYVGDSALQLER46 3 987.4786
Note. Peptides are grouped according to their origin; standard peptides are grouped by tubulin family, and reporter peptides are grouped by parent
isotype. Peptides in bold type were identified as being reliably released by trypsin. The sequences of the β-tubulin isotype peptides were obtained
using the UniProtKB/Swiss–Prot database (www.uniprot.org). Database accession numbers listed in parentheses.
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Table 2
Peptide-specific LC–MS response factors given in machine counts per picomole of peptide in each injection,
as calculated by linear regression analysis





Note. MC, machine counts.
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